168 related articles for article (PubMed ID: 33486018)
1. Mechanistic explanation of the (up to) 3 release phases of PLGA microparticles: Monolithic dispersions studied at lower temperatures.
Tamani F; Bassand C; Hamoudi MC; Siepmann F; Siepmann J
Int J Pharm; 2021 Mar; 596():120220. PubMed ID: 33486018
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic explanation of the (up to) 3 release phases of PLGA microparticles: Diprophylline dispersions.
Tamani F; Bassand C; Hamoudi MC; Danede F; Willart JF; Siepmann F; Siepmann J
Int J Pharm; 2019 Dec; 572():118819. PubMed ID: 31726196
[TBL] [Abstract][Full Text] [Related]
3. Towards a better understanding of the different release phases from PLGA microparticles: Dexamethasone-loaded systems.
Gasmi H; Siepmann F; Hamoudi MC; Danede F; Verin J; Willart JF; Siepmann J
Int J Pharm; 2016 Nov; 514(1):189-199. PubMed ID: 27543353
[TBL] [Abstract][Full Text] [Related]
4. Does PLGA microparticle swelling control drug release? New insight based on single particle swelling studies.
Gasmi H; Danede F; Siepmann J; Siepmann F
J Control Release; 2015 Sep; 213():120-127. PubMed ID: 26150116
[TBL] [Abstract][Full Text] [Related]
5. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
6. Imaging the porous structure in the core of degrading PLGA microparticles: The effect of molecular weight.
Mylonaki I; Allémann E; Delie F; Jordan O
J Control Release; 2018 Sep; 286():231-239. PubMed ID: 30071251
[TBL] [Abstract][Full Text] [Related]
7. Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles.
Klose D; Delplace C; Siepmann J
Int J Pharm; 2011 Feb; 404(1-2):75-82. PubMed ID: 21056644
[TBL] [Abstract][Full Text] [Related]
8. Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles.
Panyam J; Dali MM; Sahoo SK; Ma W; Chakravarthi SS; Amidon GL; Levy RJ; Labhasetwar V
J Control Release; 2003 Sep; 92(1-2):173-87. PubMed ID: 14499195
[TBL] [Abstract][Full Text] [Related]
9. PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release.
Faisant N; Siepmann J; Benoit JP
Eur J Pharm Sci; 2002 May; 15(4):355-66. PubMed ID: 11988397
[TBL] [Abstract][Full Text] [Related]
10. Often neglected: PLGA/PLA swelling orchestrates drug release: HME implants.
Bode C; Kranz H; Fivez A; Siepmann F; Siepmann J
J Control Release; 2019 Jul; 306():97-107. PubMed ID: 31150749
[TBL] [Abstract][Full Text] [Related]
11. Effect of particle size, polydispersity and polymer degradation on progesterone release from PLGA microparticles: Experimental and mathematical modeling.
Busatto C; Pesoa J; Helbling I; Luna J; Estenoz D
Int J Pharm; 2018 Jan; 536(1):360-369. PubMed ID: 29217474
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of PLGA microparticle properties loaded with micronized, nanosized or dissolved drug.
Zhang C; Bodmeier R
Int J Pharm; 2022 Nov; 628():122313. PubMed ID: 36272513
[TBL] [Abstract][Full Text] [Related]
13. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).
Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T
J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055
[TBL] [Abstract][Full Text] [Related]
14. How porosity and size affect the drug release mechanisms from PLGA-based microparticles.
Klose D; Siepmann F; Elkharraz K; Krenzlin S; Siepmann J
Int J Pharm; 2006 May; 314(2):198-206. PubMed ID: 16504431
[TBL] [Abstract][Full Text] [Related]
15. Effect of the size of biodegradable microparticles on drug release: experiment and theory.
Siepmann J; Faisant N; Akiki J; Richard J; Benoit JP
J Control Release; 2004 Apr; 96(1):123-34. PubMed ID: 15063035
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer.
Lee WK; Park JY; Yang EH; Suh H; Kim SH; Chung DS; Choi K; Yang CW; Park JS
J Control Release; 2002 Dec; 84(3):115-23. PubMed ID: 12468215
[TBL] [Abstract][Full Text] [Related]
17. Seeing is believing, PLGA microsphere degradation revealed in PLGA microsphere/PVA hydrogel composites.
Gu B; Sun X; Papadimitrakopoulos F; Burgess DJ
J Control Release; 2016 Apr; 228():170-178. PubMed ID: 26965956
[TBL] [Abstract][Full Text] [Related]
18. rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites.
Ruhe PQ; Hedberg EL; Padron NT; Spauwen PH; Jansen JA; Mikos AG
J Bone Joint Surg Am; 2003; 85-A Suppl 3():75-81. PubMed ID: 12925613
[TBL] [Abstract][Full Text] [Related]
19. Continuous in-line homogenization process for scale-up production of naltrexone-loaded PLGA microparticles.
Sharifi F; Otte A; Yoon G; Park K
J Control Release; 2020 Sep; 325():347-358. PubMed ID: 32645336
[TBL] [Abstract][Full Text] [Related]
20. Design of physostigmine-loaded polymeric microparticles for pretreatment against exposure to organophosphate agents.
Chaw CS; Tan CW; Yang YY; Wang L; Moochhala S
Biomaterials; 2003 Mar; 24(7):1271-7. PubMed ID: 12527268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
